VUC-67394-93124
4 vaccinations
8 coded responses
52 check-ins
8 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 480 / MI
- Registered
- 2020-12-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
WVS-30059-77566
Child or adolescent in my care · Female · 2022-06-23
Timeline
-
2020-12-23
Registered in v-safe
-
2020-12-23
Dose 1 — Pfizer-BioNTech
- 2020-12-23
-
2020-12-24
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fever · HeadacheAdult check-in
-
2020-12-25
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fever · HeadacheAdult check-in
- 2020-12-26
- 2020-12-27
- 2020-12-28
- 2020-12-29
- 2020-12-30
- 2021-01-06
-
2021-01-14
Dose 2 — Pfizer-BioNTech
- 2021-01-14
-
2021-01-15
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain · Fever · Fatigue or tirednessFree text: Swollen cervical lymph nodesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-16
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain · Fever · HeadacheFree text: Swollen cervical lymph nodesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-17
Survey response — days 1–6 daily, dose 2MedDRA: Axillary pain — Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Painful axillary nodes on same side as vaccine injectionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-17
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-01-19
Survey response — days 1–6 daily, dose 2MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good · Fatigue or tirednessFree text: Swollen/sore cervical & axillary lymph nodesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-20
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Fair · Headache, Fatigue or tirednessFree text: Swollen/painful cervical lymph nodesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-21
Survey response — day 7, dose 2MedDRA: Lymphadenopathy — Feeling: Good · Fever · Fatigue or tirednessFree text: Swollen cervical lymph nodesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-29
- 2021-02-04
- 2021-02-11
- 2021-02-19
- 2021-02-25
- 2021-04-16
- 2021-07-15
-
2021-10-20
Dose 3 — Pfizer-BioNTech
- 2021-10-20
-
2021-10-21
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tirednessAdult check-in
-
2021-10-22
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-10-23
- 2021-10-24
- 2021-10-25
- 2021-10-26
- 2021-10-27
- 2021-11-03
- 2021-11-10
- 2021-11-17
- 2021-11-24
- 2021-12-01
- 2022-01-21
-
2022-04-21
Survey response — 6 months, dose 3MedDRA: Delivery, Hospitalisation — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationFree text: Symptoms: Childbirth · Healthcare visit (other): Labor & deliveryMedDRA releases: 2024-11 · check-in free text available
-
2022-04-21
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prHospitalization · 1 call case(s)
-
2022-04-22
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-09-30
Dose 4 — Pfizer-BioNTech
-
2022-10-01
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2022-10-02
- 2022-10-03
- 2022-10-04
- 2022-10-05
- 2022-10-06
- 2022-10-07
- 2022-10-14
- 2022-10-21
- 2022-10-28
- 2022-11-04
- 2022-11-11
-
2022-12-30
Survey response — 3 months, dose 4MedDRA: Autoimmune thyroiditis, Hyperthyroidism, Hypothyroidism, Malaise, Nasopharyngitis — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Diagnosed with Hashimoto's thyroiditis; initially hyperthyroid, now hypothyroid on levothyroxine Currently ill with cold-like symptomsMedDRA releases: 2024-11 · check-in free text available
-
2022-12-30
Report sent to call center — 3 months, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2023-01-04
- 2023-03-31
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-23 | Pfizer-BioNTech | |
| 2 | 2021-01-14 | Pfizer-BioNTech | |
| 3 | 2021-10-20 | Pfizer-BioNTech | No |
| 4 | 2022-09-30 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-17 | priority 2/3 | |
| 2022-04-21 | Successful 2022-04-22 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
| 2022-12-30 | Unsuccessful |
Free text
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Swollen cervical lymph nodes
Systemic reaction (other): Swollen cervical lymph nodes
Systemic reaction (other): Painful axillary nodes on same side as vaccine injection
Systemic reaction (other): Swollen/sore cervical & axillary lymph nodes
Systemic reaction (other): Swollen/painful cervical lymph nodes
Release 2 — day 7, dose 2
Systemic reaction (other): Swollen cervical lymph nodes
Release 11 — 6 months, dose 3
Release 12 — 3 months, dose 4
Symptoms: Diagnosed with Hashimoto's thyroiditis; initially hyperthyroid, now hypothyroid on levothyroxine Currently ill with cold-like symptoms
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Hospitalisation | · | · | ✓ |
| SD | Autoimmune thyroiditis | · | · | ✓ |
| SD | Delivery | · | · | ✓ |
| SD | Hyperthyroidism | · | · | ✓ |
| SD | Hypothyroidism | · | · | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SRO | Axillary pain | ✓ | ✓ | ✓ |
| SRO | Lymph node pain | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release